![]() |
|
|
Vol. 289, Issue 2, 641-648, May 1999
Departments of
Anatomy and Cell Biology (T.F.D., P.G.F.) and
Surgery (K.R., D.P.), Queen's University, Kingston, Ontario, Canada;
Department of Surgery, University of Arizona, Tucson, Arizona (J.B.U.);
and
Vitron, Inc., Tucson, Arizona (R.B.L.)
We investigated the cytochrome P-450-dependent metabolism of
1,1-dichloroethylene (DCE) by human lung and liver microsomes and
compared the results from analogous experiments in mice. Metabolites were identified by HPLC analysis of their glutathione conjugates and/or
hydrolyzed products and were detected by using [14C]DCE.
The role of human CYP2E1 in the metabolic reactions was examined by
comparing p-nitrophenol hydroxylase activities with levels of metabolites formed and by using the CYP2E1-selective inhibitor diallyl sulfone. The major products formed in microsomal incubations containing NADPH were the DCE-epoxide-derived glutathione conjugates 2-(S-glutathionyl)acetyl glutathione and
2-S-glutathionyl acetate. Lower levels of the acetal of
2,2-dichloroacetaldehyde were also detected. In lung samples from eight
patients, the amounts of epoxide-derived conjugates formed ranged from
15.6 ± 4.23 to 34.9 ± 12.75 pmol/mg protein/min. The levels
in murine lung were higher at 40.0 ± 3.8 pmol/mg protein/min. In
liver samples from five patients, conjugate levels ranged from
46.5 ± 8.3 to 240.0 ± 10.5 pmol/mg protein/min, whereas
levels in murine liver were 83.0 ± 6.2 pmol/mg protein/min.
Conjugate levels formed in human liver correlated with the relative
levels of p-nitrophenol hydroxylase activity present,
but this relationship was equivocal in human lung. Diallyl sulfone
inhibited the formation of the glutathione conjugates (20-65%) in
liver samples from all four patients, whereas only one of five human
lung samples exhibited this inhibition (27%). These results
demonstrated that the DCE-epoxide is a major metabolite formed by human
microsomes and is mediated by CYP2E1 in liver and in some individuals
in lung.
This article has been cited by other articles:
![]() |
A. C. Simmonds, C. A. Reilly, R. M. Baldwin, B. I. Ghanayem, D. L. Lanza, G. S. Yost, K. S. Collins, and P.-G. Forkert BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES Drug Metab. Dispos., September 1, 2004; 32(9): 1032 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Simmonds, B. I. Ghanayem, A. Sharma, C. A. Reilly, B. Millen, G. S. Yost, and P.-G. Forkert Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 855 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Mastrangelo, U Fedeli, E Fadda, G Milan, A Turato, and S Pavanello Lung cancer risk in workers exposed to poly(vinyl chloride) dust: a nested case-referent study Occup. Environ. Med., June 1, 2003; 60(6): 423 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Forkert and S. M. Boyd Differential Metabolism of 1,1-Dichloroethylene in Livers of A/J, CD-1, and C57BL/6 Mice Drug Metab. Dispos., November 1, 2001; 29(11): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nemery, A. Bast, J. Behr, P.J.A. Borm, S.J. Bourke, Ph. Camus, P. De Vuyst, H.M. Jansen, V.L. Kinnula, D. Lison, et al. Interstitial lung disease induced by exogenous agents: factors governing susceptibility Eur. Respir. J., July 1, 2001; 18(32_suppl): 30S - 42s. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Forkert, R. P. Lee, and K. Reid Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate Metabolism in Human Lung Microsomes Drug Metab. Dispos., March 1, 2001; 29(3): 258 - 263. [Abstract] [Full Text] |
||||
![]() |
P.-G. Forkert, P. D. Premdas, and R. J. Bowers Epoxide Formation from Diallyl Sulfone Is Associated with CYP2E1 Inactivation in Murine and Human Lungs Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 687 - 695. [Abstract] [Full Text] |
||||